These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 13976232)

  • 1. On the re-isolation and taxonomic study of Candida viswanathii Viswanathan et Randhawa 1959.
    SANDHU RS; RANDHAWA HS
    Mycopathol Mycol Appl; 1962 Nov; 18():179-83. PubMed ID: 13976232
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenicity of Candida viswanathii for normal and cortisone-treated mice.
    Randhawa HS; Mishra SK; Damodaran VN; Prakash A; Chowdhary A; Khan ZU
    J Mycol Med; 2015 Dec; 25(4):287-92. PubMed ID: 26597146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of Candida viswanathii from cerebrospinal fluid.
    Sandhu DK; Sandhu RS; Misra VC
    Sabouraudia; 1976 Nov; 14(3):251-4. PubMed ID: 996690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α, ω-Dodecanedioic acid production by Candida viswanathii ipe-1 with co-utilization of wheat straw hydrolysates and n-dodecane.
    Cao W; Liu B; Luo J; Yin J; Wan Y
    Bioresour Technol; 2017 Nov; 243():179-187. PubMed ID: 28662387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level productivity of α,ω-dodecanedioic acid with a newly isolated Candida viswanathii strain.
    Cao W; Li H; Luo J; Yin J; Wan Y
    J Ind Microbiol Biotechnol; 2017 Aug; 44(8):1191-1202. PubMed ID: 28451837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Typing and Antifungal Susceptibility of Candida viswanathii, India.
    Shankarnarayan SA; Rudramurthy SM; Chakrabarti A; Shaw D; Paul S; Sethuraman N; Kaur H; Ghosh AK
    Emerg Infect Dis; 2018 Oct; 24(10):1956-1958. PubMed ID: 30226183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of iso-pentylbenzene by a biofilm-forming strain of Candida viswanathii TH1 isolated from oil-polluted sediments collected in coastal zones in Vietnam.
    Cong le TN; Ngoc Mai CT; Morikawa M; Ngoc Minh N
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2014; 49(7):777-86. PubMed ID: 24679085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single cell oil production from a newly isolated Candida viswanathii Y-E4 and agro-industrial by-products valorization.
    Ayadi I; Kamoun O; Trigui-Lahiani H; Hdiji A; Gargouri A; Belghith H; Guerfali M
    J Ind Microbiol Biotechnol; 2016 Jul; 43(7):901-14. PubMed ID: 27114386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA hybridization and electrokaryotype study of some Candida species.
    Lee FL; Fu HM; Hsu WH
    Int J Syst Bacteriol; 1998 Oct; 48 Pt 4():1463-6. PubMed ID: 9828450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemical composition of polysaccharides isolated from Candida viswanathii and Candida tropicalis].
    Elinov NP; Surinova MD
    Mikrobiologiia; 1968; 37(2):277-80. PubMed ID: 5732073
    [No Abstract]   [Full Text] [Related]  

  • 11. Peculiarities of the polysaccharide haptens from Candida viswanathii and Candida tropicalis.
    Elinov NP
    Antonie Van Leeuwenhoek; 1969 Jun; 35():Suppl:E3-4. PubMed ID: 5311975
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathogenicity of various species of Candida in an experimental murine system].
    Perito S; Vecchiarelli L; D'Errico P; Serafini S; Sbaraglia G
    Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1415-9. PubMed ID: 6477756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some characteristics of soluble polysaccharides from Candida tropicalis and Candida viswanathii].
    Elinov NP; Surinova MD
    Biokhimiia; 1968; 33(6):1272-8. PubMed ID: 4303736
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathogenicity of Candida viswanathii for laboratory animals. A preliminary study.
    Sandhu RS; Randhawa HS; Gupta IM
    Sabouraudia; 1965 Feb; 4(1):37-40. PubMed ID: 5873444
    [No Abstract]   [Full Text] [Related]  

  • 15. The application of UV resonance Raman spectroscopy for the differentiation of clinically relevant Candida species.
    Silge A; Heinke R; Bocklitz T; Wiegand C; Hipler UC; Rösch P; Popp J
    Anal Bioanal Chem; 2018 Sep; 410(23):5839-5847. PubMed ID: 29959486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of physicochemical parameters for the enhancement of carbonyl reductase production by Candida viswanathii.
    Soni P; Prasad GS; Banerjee UC
    Bioprocess Biosyst Eng; 2006 Aug; 29(3):149-56. PubMed ID: 16770591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response surface optimization of the critical medium components for carbonyl reductase production by Candida viswanathii MTCC 5158.
    Soni P; Singh M; Kamble AL; Banerjee UC
    Bioresour Technol; 2007 Mar; 98(4):829-33. PubMed ID: 16697185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the biocatalytic potential of carbonyl reductase of Candida viswanathii using aqueous-organic solvent system.
    Kansal H; Banerjee UC
    Bioresour Technol; 2009 Feb; 100(3):1041-7. PubMed ID: 18840394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeasts isolation from bovine mammary glands under different mastitis status in the Mexican High Plateu.
    Zaragoza CS; Olivares RA; Watty AE; Moctezuma Ade L; Tanaca LV
    Rev Iberoam Micol; 2011; 28(2):79-82. PubMed ID: 21349344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenicity of various species of Candida in mice immunodepressed with cyclophosphamide].
    Sbaraglia G; D'Errico P; Serafini S; Vecchiarelli L; Perito S
    Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1421-6. PubMed ID: 6477757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.